Cargando…

Sjögren’s syndrome: novel insights from proteomics and miRNA expression analysis

INTRODUCTION: Sjögren’s syndrome (SS) is a systemic autoimmune disease, which affects the exocrine glands leading to glandular dysfunction and, particularly, symptoms of oral and ocular dryness. The aetiology of SS remains unclear, and the disease lacks distinctive clinical features. The current dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamounah, Sarah, Sembler-Møller, Maria Lynn, Nielsen, Claus Henrik, Pedersen, Anne Marie Lynge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232878/
https://www.ncbi.nlm.nih.gov/pubmed/37275849
http://dx.doi.org/10.3389/fimmu.2023.1183195
Descripción
Sumario:INTRODUCTION: Sjögren’s syndrome (SS) is a systemic autoimmune disease, which affects the exocrine glands leading to glandular dysfunction and, particularly, symptoms of oral and ocular dryness. The aetiology of SS remains unclear, and the disease lacks distinctive clinical features. The current diagnostic work-up is complex, invasive and often time-consuming. Thus, there is an emerging need for identifying disease-specific and, ideally, non-invasive immunological and molecular biomarkers that can simplify the diagnostic process, allow stratification of patients, and assist in monitoring the disease course and outcome of therapeutic intervention in SS. METHODS: This systematic review addresses the use of proteomics and miRNA-expression profile analyses in this regard. RESULTS AND DISCUSSION: Out of 272 papers that were identified and 108 reviewed, a total of 42 papers on proteomics and 23 papers on miRNA analyses in saliva, blood and salivary gland tissue were included in this review. Overall, the proteomic and miRNA studies revealed considerable variations with regard to candidate biomarker proteins and miRNAs, most likely due to variation in sample size, processing and analytical methods, but also reflecting the complexity of SS and patient heterogeneity. However, interesting novel knowledge has emerged and further validation is needed to confirm their potential role as biomarkers in SS.